Call for a pan-European COVID-19 response must be comprehensive - Authors' reply
- PMID: 33894827
- PMCID: PMC9754104
- DOI: 10.1016/S0140-6736(21)00462-1
Call for a pan-European COVID-19 response must be comprehensive - Authors' reply
Conflict of interest statement
SCi reports grants and personal fees from Roche, and personal fees from Euroimmun, unrelated to this Correspondence. NH reports grants from GSK Biologicals, Pfizer, Merck, and Johnson & Johnson, unrelated to this Correspondence. All other authors declare no competing interests.
Comment on
-
Call for a pan-European COVID-19 response must be comprehensive.Lancet. 2021 Apr 24;397(10284):1540-1541. doi: 10.1016/S0140-6736(21)00471-2. Lancet. 2021. PMID: 33894826 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
